DHFR and acute lymphoblastic leukemia: Corroborating our findings, one study evaluated the DHFR 19-pb ins/del (rs70991108) polymorphism in mother/child dyads in acute lymphoblastic leukemia onset-latency and demonstrated a good prognosis for carrier patients with homozygous deletion (Tisato et al., 2019).